Kayla Long, DO | |
1901 Tate Springs Rd, Lynchburg, VA 24501-1109 | |
(434) 200-3000 | |
Not Available |
Full Name | Kayla Long |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Location | 1901 Tate Springs Rd, Lynchburg, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215166293 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 0102204187 (Virginia) | Primary |
Entity Name | Centra Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649228966 PECOS PAC ID: 4789606088 Enrollment ID: O20051230000147 |
News Archive
Researchers at The Wistar Institute announce the discovery of small molecules that kill cancer cells caused by infection with human papillomavirus (HPV). Their results, in both cell and mouse models, demonstrate that the small molecule inhibitors protect a tumor-suppressing protein targeted by viral proteins, thus killing the infected tumor cells.
Down syndrome is a well known cause of mental retardation and other medical problems, including early onset of Alzheimer disease. It has long been known that Down syndrome is associated with an individual having an additional copy of chromosome 21. Research findings reported in the July 18 advanced online publication of Nature Neuroscience have narrowed down the critical genetic elements responsible for some aspects of Down syndrome.
A new study may explain why only 50% of patients experiencing chronic nerve pain achieve even partial relief from existing therapeutics. The study, published in the June 6 online version of the international research journal PAIN, reveals that certain types of chronic pain may be caused by signals from the skin itself, rather than damage to nerves within the skin, as previously thought.
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Kayla Long, DO 1901 Tate Springs Rd, Lynchburg, VA 24501-1109 Ph: (434) 200-3000 | Kayla Long, DO 1901 Tate Springs Rd, Lynchburg, VA 24501-1109 Ph: (434) 200-3000 |
News Archive
Researchers at The Wistar Institute announce the discovery of small molecules that kill cancer cells caused by infection with human papillomavirus (HPV). Their results, in both cell and mouse models, demonstrate that the small molecule inhibitors protect a tumor-suppressing protein targeted by viral proteins, thus killing the infected tumor cells.
Down syndrome is a well known cause of mental retardation and other medical problems, including early onset of Alzheimer disease. It has long been known that Down syndrome is associated with an individual having an additional copy of chromosome 21. Research findings reported in the July 18 advanced online publication of Nature Neuroscience have narrowed down the critical genetic elements responsible for some aspects of Down syndrome.
A new study may explain why only 50% of patients experiencing chronic nerve pain achieve even partial relief from existing therapeutics. The study, published in the June 6 online version of the international research journal PAIN, reveals that certain types of chronic pain may be caused by signals from the skin itself, rather than damage to nerves within the skin, as previously thought.
With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.
› Verified 2 days ago
Sean Mlodzinski, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-3000 | |
Samuel Adam Morcom, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-229-6384 | |
Benjamin Newman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-6858 | |
Dr. Timothy Alan Coakley, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-3027 | |
Dr. Eric R. Van Buskirk, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1509 Lexington Dr, Lynchburg, VA 24503 Phone: 434-384-5132 | |
Dr. Sarah Anne Dooley Sebby, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-3027 | |
Cameron Dean Cook, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-3027 Fax: 434-200-3265 |